Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Medical Genetics · Short-Chain Acyl-CoA Dehydrogenase Deficiency

Management, Precautions, and Follow-Up

At a Glance

Most babies with Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCADD) lead healthy, normal lives without strict diets. The most critical medical precaution is to strictly avoid the medication valproic acid, which can cause dangerous metabolic imbalances in individuals with SCADD.

Because modern medicine increasingly views SCADD (Short-Chain Acyl-CoA Dehydrogenase Deficiency) as a “biochemical entity” rather than a clinical disease, daily life for most families is completely normal [1][2]. In the majority of cases, your baby will not require a special diet, frequent hospital visits, or intensive medical monitoring [3][4].

However, because SCADD affects how the body processes certain fats, there are a few specific precautions and follow-up steps you should be aware of.

Medication Precautions: Valproic Acid

The most important medical precaution for a child with SCADD is the avoidance of a specific medication called valproic acid (VPA) [5].

  • What it is: Valproic acid is a common medication used to treat seizures and certain psychiatric conditions.
  • The Risk: VPA can interfere with fatty acid oxidation—the very process that is already slightly less efficient in babies with SCADD [5]. In people with SCADD, VPA can cause a dangerous buildup of ammonia (hyperammonemia) or other metabolic imbalances [6][7].
  • Action Step: Always inform any doctor treating your child (including neurologists or ER physicians) that they have a SCAD deficiency and should not be prescribed valproic acid [5].

Fasting and Illness

For many other fatty acid oxidation disorders, strictly limiting how long a baby goes without food (fasting) is critical. In SCADD, the need for these precautions is a subject of debate [2][1].

  • Standard Care: Most asymptomatic infants with SCADD do not require strict fasting limits and can follow a normal feeding schedule [3][8].
  • Illness Protocol: During common childhood illnesses, like a stomach bug where a child may not want to eat, some metabolic specialists may still recommend being cautious [9]. They may suggest encouraging small, frequent sips of liquids containing sugar (like Pedialyte) to ensure the body has enough glucose and doesn’t have to rely heavily on burning fats.

Long-Term Monitoring

Because the long-term outlook for screen-detected SCADD is excellent, different clinics have different approaches to follow-up care [3][4].

  • Infrequent Check-ups: Some metabolic specialists may want to see your child once a year to monitor their growth and development and ensure they are meeting milestones [10][9].
  • Genetic Guidance: If your baby has the “common” genetic variants and remains healthy, some clinics may eventually discharge you from their care, concluding that the SCADD is an incidental finding of no clinical concern [2][1].
  • Emergency Letters: In some cases, your doctor may provide an “Emergency Letter.” This is a document you can bring to the ER if your child is very sick, explaining their metabolic profile and providing instructions for IV fluids if they cannot keep food down [3].

While the term “deficiency” sounds permanent and serious, the reality for a child with SCADD is usually one of health and typical development [11][8]. Your primary “job” is simply to keep their care team informed about this unique biochemical trait [5].

Common questions in this guide

Does my baby with SCADD need a special diet or fasting rules?
In the majority of cases, babies with SCADD do not require a special diet or strict fasting limits. They can typically follow a normal feeding schedule and live healthy lives like any other child.
What medications should be avoided with SCADD?
Children with SCADD must strictly avoid valproic acid, a medication commonly used to treat seizures and certain psychiatric conditions. Valproic acid can interfere with fat processing and cause dangerous metabolic imbalances like high ammonia levels.
How should I manage my baby's feeding during a stomach flu or illness?
During common illnesses where your child may not want to eat, metabolic specialists often recommend offering small, frequent sips of liquids containing sugar, such as Pedialyte. This ensures the body has enough glucose and doesn't have to rely heavily on burning fats for energy.
Will my child need frequent doctor visits for SCADD?
Because the long-term outlook for SCADD is excellent, most children only need infrequent check-ups, such as an annual visit to monitor standard growth and milestones. If your baby remains healthy, your clinic may eventually discharge you from their care completely.
Why do I need an emergency letter for the hospital?
Many metabolic doctors provide an emergency letter that explains your child's specific metabolic profile. You can bring this document to the ER if your child is very sick, as it provides medical staff with crucial instructions for treatments like IV fluids.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my baby need a special diet or a restricted fasting schedule?
  2. 2.Should we have an 'emergency letter' for the hospital, or is that unnecessary given my baby's specific genetic variants?
  3. 3.How often do we need to return for follow-up appointments? Is it possible we will eventually be discharged from the metabolic clinic?
  4. 4.If my baby ever needs medication for seizures, what are the safe alternatives to valproic acid?
  5. 5.Do I need to worry about my baby's blood sugar during common illnesses like a stomach flu?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Diverse and unselected adults with clinically relevant ACADS variants lack evidence of metabolic disease.

    Breilyn MS, Kenny EE, Abul-Husn NS

    Molecular genetics and metabolism 2023; (138(1)):106971 doi:10.1016/j.ymgme.2022.106971.

    PMID: 36549199
  2. 2

    Tread carefully: A functional variant in the human NADPH oxidase 4 (NOX4) is not disease causing.

    Nafisinia M, Menezes MJ, Gold WA, et al.

    Molecular genetics and metabolism 2018; (123(3)):382-387 doi:10.1016/j.ymgme.2018.01.007.

    PMID: 29398271
  3. 3

    Clinical characteristics and related gene mutations of infants with short-chain acyl-CoA dehydrogenase deficiency by neonatal screening in Beijing.

    Gong L, Yang N, Zhao J, et al.

    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2022; (51(3)):278-283 doi:10.3724/zdxbyxb-2022-0214.

    PMID: 36207829
  4. 4

    [Clinical, biochemical and gene mutation characteristics of short chain acyl-coenzyme A dehydrogenase deficiency by neonatal screening].

    Huang XW, Zhang Y, Yang JB, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2016; (54(12)):927-930 doi:10.3760/cma.j.issn.0578-1310.2016.12.011.

    PMID: 27938594
  5. 5

    Unexpected elevation in valproic acid concentration and agranulocytosis in a patient with short-chain acyl-CoA dehydrogenase deficiency.

    Suzuki Y, Ito S, Otani Y, et al.

    Brain & development 2021; (43(5)):657-660 doi:10.1016/j.braindev.2021.01.001.

    PMID: 33549404
  6. 6

    Clinical, biochemical, and molecular spectrum of short/branched-chain acyl-CoA dehydrogenase deficiency: two new cases and review of literature.

    Porta F, Chiesa N, Martinelli D, Spada M

    Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(2)):101-108.

    PMID: 30730842
  7. 7

    Valproic Acid-Associated Hyperammonemia: A Systematic Review.

    Wong YJ, Fan J, Wan A, et al.

    Journal of clinical psychopharmacology 2023; (43(3)):283-294 doi:10.1097/JCP.0000000000001689.

    PMID: 37126830
  8. 8

    Compound heterozygous mutations of ACADS gene in newborn with short chain acyl-CoA dehydrogenase deficiency: case report and literatures review.

    An SJ, Kim SZ, Kim GH, et al.

    Korean journal of pediatrics 2016; (59(Suppl 1)):S45-S48 doi:10.3345/kjp.2016.59.11.S45.

    PMID: 28018444
  9. 9

    Retrospective analysis of isobutyryl CoA dehydrogenase deficiency.

    Zhang Z, Sun Y, Wang YY, et al.

    Minerva pediatrics 2024; (76(5)):645-651 doi:10.23736/S2724-5276.21.06179-6.

    PMID: 34647701
  10. 10

    Clinical relevance of short-chain acyl-CoA dehydrogenase (SCAD) deficiency: Exploring the role of new variants including the first SCAD-disease-causing allele carrying a synonymous mutation.

    Tonin R, Caciotti A, Funghini S, et al.

    BBA clinical 2016; (5()):114-9 doi:10.1016/j.bbacli.2016.03.004.

    PMID: 27051597
  11. 11

    Newborn screening, genetic analysis, and long-term follow-up of 89 cases with short-chain acyl-CoA dehydrogenase deficiency (SCADD).

    Qian G, Liu C, Xu Y, et al.

    Molecular genetics and metabolism reports 2026; (46()):101292 doi:10.1016/j.ymgmr.2026.101292.

    PMID: 41716778

This page provides educational information about SCADD management and precautions. Always consult your metabolic specialist or pediatrician before making medical decisions, starting new medications, or managing childhood illnesses.

Get notified when new evidence is published on Short chain acyl-CoA dehydrogenase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.